Patient characteristics | Number (n=143) |
---|---|
Median age (range) | 54 (30–81) |
FIGO stage | |
I | 82 (57%) |
II | 20 (14%) |
III | 28 (20%) |
IV | 13 (9%) |
Histology | |
Pure type | 134 (94%) |
Mixed type | 9 (6%) |
Serous | 4 (3%) |
Mucinous | 2 (1%) |
Endometrioid | 2 (1%) |
Cystadenocarcinofibroma | 1 (1%) |
Positive peritoneal cytology | 66 (46%) |
Endometriosis | |
Present | 74 (52%) |
Absent | 69 (48%) |
Treatment | |
Surgery | 143 (100%) |
Lymph node adenectomy | 112 (78%) |
Lymph node sampling | 5 (3%) |
Chemotherapy | 136 (95%) |
Platinum | 135 (94%) |
Taxane | 122 (85%) |
CPT-11 | 19 (13%) |
Residual tumor present | 20 (14%) |